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1. From consumption to addiction: understanding the course of disease 
Current research on alcohol and drug dependence gradually showed that the development 
of addiction has to be understood as a complex interplay of psychological factors and 
neurobiological adaptation processes induced by consumption-related behavioural changes. 
Therefore, we review the results of recent neuroimaging research in humans that tried to 
understand the development of drug addiction in each of its stages. After giving an 
introduction to the imaging techniques and to the main neuroanatomical and –chemical 
targets of addiction research, we review changes in the brains’ neuronal networks and in 
relevant neurotransmitter systems related to the processing of substance-related stimuli. We 
continue by reporting alterations in attention networks and memory formation, which are 
considered to be relevant for sustaining drug intake. We proceed by outlining imaging 
results on phenomena which are considered to define addiction itself like craving and 
withdrawal. Finally, we give an overview on neuroimaging research on relapse risk. We 
conclude with some comments on possible therapeutical implications of recent imaging 
results and on future perspectives. 
 
1.1 Methodological approaches 
Technical improvement in the neurosciences has provided powerful tools for research on 
functional brain activity related to addictive behaviour in humans. There are different 
imaging techniques which are most commonly used during the last decade. Since the 
neuroscientific methods used also give us information about scientific questions which 
could not yet be answered, the available imaging methods will shortly be addressed from a 
methodological point of view. 
One way to understand the brains’ functional organisation is using the functional Magnetic 
Resonance Imaging (fMRI) technique. This method allows for indirectly assessing neuronal 
activity by measuring changes in local blood flow. In detail, it measures the ratio of 
oxygenated and des-oxygenated blood, the so called blood oxygen level dependent (BOLD) 
contrast. This allows for an estimation of the underlying neural activity, since it has been 
shown that changes in blood flow and blood oxygenation are linked to neuronal activity 
(Kwong et al., 1992; Logothetis, 2002; Ogawa et al., 1990). fMRI is one of the most prominent 
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neuroimaging techniques because of its non-invasiveness, the lack of radiation exposure, the 
relatively high availability and its good spatial resolution. Disadvantages of the method are 
the rather poor temporal resolution (e.g. versus EEG), the lack of an absolute baseline of 
activity and the fact that specific neurotransmitter systems can not be systematically 
assessed without applying specific agonists/ antagonists. 
In contrast to fMRI, the so called Positron Emission Tomography (PET) as well as Single 
Photon Emission Computed Tomography (SPECT) allow for measurement of an absolute 
baseline of activation. Furthermore, these imaging methods can quantify neuroreceptor and 
transporter availabilities, although a potential confound of endogenous neurotransmitter 
concentration competing for binding of receptors/ transporters with radioligands has to be 
taken into account (Heinz et al., 2004a; Kumakura et al., 2007; Laruelle 2000). 
Clear disadvantages of PET and SPECT measurements are the application of a radioactive 
contrast agent exposing the subject to gamma radiation, the often rather short half-life 
period of the commonly used tracers and the rather high expenses required. 
An elegant way to link specific brain functions with certain neurotransmitter systems, like 
linking dopamine with the brain reward system, is to use the combination of both methods: 
the correlation of neuronal activation measured with fMRI and functions of 
neurotransmitter system measured with PET or SPECT, e.g. dopamine receptor D2 
availability or dopamine synthesis rate (Kienast et al., 2008). 
 
1.2 Neuroanatomical core structures 
Considerable progress has been made during the last two decades in the attempt to identify 
the basic neuronal mechanisms that underlie addictive behaviour. Animal studies revealed 
that alcohol- and drug-associated cues activate dopamine and endorphin release in the 
medial prefrontal cortex and the ventral striatum including the nucleus accumbens, a core 
area of the brains’ reward system (Dayas et al., 2007; Di Chiara, 2002; Shalev et al., 2000). As 
already mentioned, functional brain activity related to addictive behaviour in humans can 
be indirectly assessed by measuring changes in cerebral blood flow with PET, SPECT or by 
measuring the BOLD response with fMRI. These neuroscientific techniques gain insight into 
the neurobiology of addiction when combined with paradigms, which are designed to study 
single components of addiction and its development, e.g. so-called “cue-reactivity” 
paradigms (e.g. Braus et al., 2001; Drummond, 2000; George et al., 2001; Grüsser et al., 2004). 
As it might be expected, studies reveal differing results regarding the main neuroanatomical 
regions of interest, depending e.g. on the specific paradigm used and on inter-individual 
differences in the functional neuroanatomy related to addiction. Nevertheless, there are 
some core regions in the brain which are repeatedly activated by drug-specific stimuli across 
studies: 1. The anterior cingulate cortex (ACC) and the adjacent medial prefrontal cortex. 
This brain region is considered to be involved in processes encoding the motivational value 
of a stimulus. Therefore, it is also of importance for attention and memory processes 
(Grüsser et al., 2004; Heinz et al., 2004b; Myrick et al., 2004; Tapert et al., 2004). 2. The 
orbitofrontal cortex (OFC). This brain area has been related to the evaluation of the reward 
value of processed stimuli (Myrick et al., 2004; Wrase et al., 2002). 3. The amygdala, mainly 
the basolateral part. The amygdala is known to represent the emotional salience of stimuli 
and it is involved in unconditioned and conditioned approach and avoidance behaviour 
(Schneider et al., 2001). 4. The ventral striatum including the nucleus accumbens. These 
brain regions are considered to code the motivational aspects of salient stimuli and to link 
with motor reactions (Wrase et al., 2007; Braus et al., 2001; Wrase et al., 2002). 5. The dorsal 
striatum. It has been implicated in habit formation and the consolidation of stimulus-
reaction-patterns (Grüsser et al., 2004; Modell & Mountz, 1995). 6. The dorsolateral 
prefrontal cortex (DLPFC). It contributes to the executive control of behaviour and might 
therefore be relevant for resisting craving for the substance of abuse (George et al., 2001) and 
to guide behavioural adaptation and learning (Park et al., 2010). 
 
1.3 Relevant neurotransmitter systems  
Beside the main neuroanatomical correlates of the development of alcohol and drug 
addiction, modern imaging methods like PET provide a powerful tool for the systematic 
examination of the underlying neurotransmitter systems and their changes. The first 
relevant neurotransmitter to mention in the context of the development of addiction is 
dopamine. All drugs of abuse are known to release dopamine, which reinforces drug-taking 
behaviour (Di Chiara & Bassareo, 2007) and chronically induces counter-adaptive processes 
such as receptor down-regulation (Koob, 2003). To give an example, PET studies in 
detoxified alcoholic showed a reduction of availability and sensitivity of central dopamine 
D2-receptors, which can serve as an example of a neuroadaptive process after chronic 
alcohol consumption, which was further associated with the subsequent relapse risk (Heinz 
et al., 1996; Volkow et al., 1996). 
A different mechanism is implicated by sensitisation: Neuroadaptation in terms of long-
term sensitisation towards the effects of drugs and drug-associated stimuli can be caused by 
structural changes in striatal GABAergic neurons, which are innervated by dopaminergic 
neurons and play a major role in the signal transfer towards the thalamus and the cortex 
(Robinson & Kolb, 1997). Drugs like alcohol also appear to directly stimulate GABA 
receptors and inhibits the function of glutamatergic NMDA-receptors (Kalivas & Volkow, 
2005; Krystal et al., 2006). 
The cannabinoid and opioidergic system are other neurotransmitter systems, which are 
involved in the development and maintenance of drug abuse. High concentrations of CB1-
receptors are found in the prefrontal cortex, the ventral tegmental area, the amygdala, the 
hippocampus, and the ventral striatum including the nucleus accumbens, i.e. structures 
which are known to be of high relevance for addiction development. Further, CB1-receptors 
modulate the release of dopamine, GABA and glutamate and elicit long-term changes in 
synaptic neurotransmission, like long-term potentiation or depression (De Vries & 
Schoffelmeer, 2005), which may play a role in addiction-specific neuroadaptations. 
 
2. Learning to maintain consumption 
Brain-imaging studies have increasingly focused on the early phase of disease, i.e. 
researchers are more and more interested in identifying addiction-specific risk factors as 
well as in describing the initial behavioural processes and the resulting neuronal changes. 
Therefore, current imaging studies try to identify the neuronal correlates of learning 
processes including classical Pavlovian and instrumental conditioning involved in disease 
development as well as in the risk of relapse. On the one hand, the goal of such studies is to 
provide insight into the neurobiology of drug addiction and therefore to improve 
understanding of the brain. On the other hand, researches intend to provide new options for 
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neuroimaging techniques because of its non-invasiveness, the lack of radiation exposure, the 
relatively high availability and its good spatial resolution. Disadvantages of the method are 
the rather poor temporal resolution (e.g. versus EEG), the lack of an absolute baseline of 
activity and the fact that specific neurotransmitter systems can not be systematically 
assessed without applying specific agonists/ antagonists. 
In contrast to fMRI, the so called Positron Emission Tomography (PET) as well as Single 
Photon Emission Computed Tomography (SPECT) allow for measurement of an absolute 
baseline of activation. Furthermore, these imaging methods can quantify neuroreceptor and 
transporter availabilities, although a potential confound of endogenous neurotransmitter 
concentration competing for binding of receptors/ transporters with radioligands has to be 
taken into account (Heinz et al., 2004a; Kumakura et al., 2007; Laruelle 2000). 
Clear disadvantages of PET and SPECT measurements are the application of a radioactive 
contrast agent exposing the subject to gamma radiation, the often rather short half-life 
period of the commonly used tracers and the rather high expenses required. 
An elegant way to link specific brain functions with certain neurotransmitter systems, like 
linking dopamine with the brain reward system, is to use the combination of both methods: 
the correlation of neuronal activation measured with fMRI and functions of 
neurotransmitter system measured with PET or SPECT, e.g. dopamine receptor D2 
availability or dopamine synthesis rate (Kienast et al., 2008). 
 
1.2 Neuroanatomical core structures 
Considerable progress has been made during the last two decades in the attempt to identify 
the basic neuronal mechanisms that underlie addictive behaviour. Animal studies revealed 
that alcohol- and drug-associated cues activate dopamine and endorphin release in the 
medial prefrontal cortex and the ventral striatum including the nucleus accumbens, a core 
area of the brains’ reward system (Dayas et al., 2007; Di Chiara, 2002; Shalev et al., 2000). As 
already mentioned, functional brain activity related to addictive behaviour in humans can 
be indirectly assessed by measuring changes in cerebral blood flow with PET, SPECT or by 
measuring the BOLD response with fMRI. These neuroscientific techniques gain insight into 
the neurobiology of addiction when combined with paradigms, which are designed to study 
single components of addiction and its development, e.g. so-called “cue-reactivity” 
paradigms (e.g. Braus et al., 2001; Drummond, 2000; George et al., 2001; Grüsser et al., 2004). 
As it might be expected, studies reveal differing results regarding the main neuroanatomical 
regions of interest, depending e.g. on the specific paradigm used and on inter-individual 
differences in the functional neuroanatomy related to addiction. Nevertheless, there are 
some core regions in the brain which are repeatedly activated by drug-specific stimuli across 
studies: 1. The anterior cingulate cortex (ACC) and the adjacent medial prefrontal cortex. 
This brain region is considered to be involved in processes encoding the motivational value 
of a stimulus. Therefore, it is also of importance for attention and memory processes 
(Grüsser et al., 2004; Heinz et al., 2004b; Myrick et al., 2004; Tapert et al., 2004). 2. The 
orbitofrontal cortex (OFC). This brain area has been related to the evaluation of the reward 
value of processed stimuli (Myrick et al., 2004; Wrase et al., 2002). 3. The amygdala, mainly 
the basolateral part. The amygdala is known to represent the emotional salience of stimuli 
and it is involved in unconditioned and conditioned approach and avoidance behaviour 
(Schneider et al., 2001). 4. The ventral striatum including the nucleus accumbens. These 
brain regions are considered to code the motivational aspects of salient stimuli and to link 
with motor reactions (Wrase et al., 2007; Braus et al., 2001; Wrase et al., 2002). 5. The dorsal 
striatum. It has been implicated in habit formation and the consolidation of stimulus-
reaction-patterns (Grüsser et al., 2004; Modell & Mountz, 1995). 6. The dorsolateral 
prefrontal cortex (DLPFC). It contributes to the executive control of behaviour and might 
therefore be relevant for resisting craving for the substance of abuse (George et al., 2001) and 
to guide behavioural adaptation and learning (Park et al., 2010). 
 
1.3 Relevant neurotransmitter systems  
Beside the main neuroanatomical correlates of the development of alcohol and drug 
addiction, modern imaging methods like PET provide a powerful tool for the systematic 
examination of the underlying neurotransmitter systems and their changes. The first 
relevant neurotransmitter to mention in the context of the development of addiction is 
dopamine. All drugs of abuse are known to release dopamine, which reinforces drug-taking 
behaviour (Di Chiara & Bassareo, 2007) and chronically induces counter-adaptive processes 
such as receptor down-regulation (Koob, 2003). To give an example, PET studies in 
detoxified alcoholic showed a reduction of availability and sensitivity of central dopamine 
D2-receptors, which can serve as an example of a neuroadaptive process after chronic 
alcohol consumption, which was further associated with the subsequent relapse risk (Heinz 
et al., 1996; Volkow et al., 1996). 
A different mechanism is implicated by sensitisation: Neuroadaptation in terms of long-
term sensitisation towards the effects of drugs and drug-associated stimuli can be caused by 
structural changes in striatal GABAergic neurons, which are innervated by dopaminergic 
neurons and play a major role in the signal transfer towards the thalamus and the cortex 
(Robinson & Kolb, 1997). Drugs like alcohol also appear to directly stimulate GABA 
receptors and inhibits the function of glutamatergic NMDA-receptors (Kalivas & Volkow, 
2005; Krystal et al., 2006). 
The cannabinoid and opioidergic system are other neurotransmitter systems, which are 
involved in the development and maintenance of drug abuse. High concentrations of CB1-
receptors are found in the prefrontal cortex, the ventral tegmental area, the amygdala, the 
hippocampus, and the ventral striatum including the nucleus accumbens, i.e. structures 
which are known to be of high relevance for addiction development. Further, CB1-receptors 
modulate the release of dopamine, GABA and glutamate and elicit long-term changes in 
synaptic neurotransmission, like long-term potentiation or depression (De Vries & 
Schoffelmeer, 2005), which may play a role in addiction-specific neuroadaptations. 
 
2. Learning to maintain consumption 
Brain-imaging studies have increasingly focused on the early phase of disease, i.e. 
researchers are more and more interested in identifying addiction-specific risk factors as 
well as in describing the initial behavioural processes and the resulting neuronal changes. 
Therefore, current imaging studies try to identify the neuronal correlates of learning 
processes including classical Pavlovian and instrumental conditioning involved in disease 
development as well as in the risk of relapse. On the one hand, the goal of such studies is to 
provide insight into the neurobiology of drug addiction and therefore to improve 
understanding of the brain. On the other hand, researches intend to provide new options for 
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specific behavioural interventions or psychopharmacological modification of alcohol 
craving and the risk of relapse. 
 
2.1 Contextual cues 
One important factor in the development of addiction is the occurrence of conditioned 
reactions elicited by conditioned cues, i.e. stimuli that have previously been associated with 
alcohol or drug consumption. For example, if an originally neutral stimulus (UCS), like a 
drinking glass, has been regularly associated with the consumption of a substance of abuse, 
like wine or other alcoholic beverages, the stimulus will also be associated with the 
positively experienced effects of alcohol as an unconditioned response (UCR) and turns into 
a conditioned stimulus (CS). As a consequence, this stimulus can itself provoke 
consumption or associated behavior as a conditioned response (CR; see Figure 1).  
 
 Fig. 1. Model of conditioned alcohol consumption: a previously unconditioned stimulus 
(UCS; e.g. wine glass) is regularly associated with alcohol consumption. Thus, it becomes 
associated with the alcohol effect as an unconditioned response (UCR) and changes to a 
conditioned stimulus (CS). The CS itself is then able to elicit alcohol craving and even 
relapse as a conditioned response (CR). 
 
In opiate addiction, studies in animals and humans demonstrated that heroin-associated 
environmental cues triggered conditioned reactions that counteract the expected drug effect 
(Wikler, 1948; Siegel et al., 1975, 1982). Rodents which received opiate always in the same 
cage showed a rather high tolerance to the opiate effects until they received the same dose in 
a different cage. In the latter case, the conditioned counter-adaptive response did not occur 
and the animals died of an overdose of opiate. On the other hand, the animals showed 
symptoms of opiate withdrawal if they did not receive the expected opiate dose after being 
exposed to the contextual cue, i.e. the habitual cage. Likewise in humans, cues 
characterizing situations of alcohol or drug intake and their associated effects may act as 
conditioned stimuli that trigger counter-adaptive alterations in neurotransmission. Such 
changes may manifest as subjectively aversive withdrawal symptoms and lead to repeated 
drug intake, i.e. trigger relapse (Verheul et al., 1999). 
 
2.2 Reward-associated changes in salience 
If a person is repeatedly exposed to a drug or alcohol intake, different neuroadaptive 
changes are considered to happen. One important aspect is that our brains’ attentional 
network is highly effective in learning to react to contextual or internal stimuli which are of 
high relevance, i.e. of high salience. Robinson and Berridge (1993) suggested that phasic 
dopamine release facilitates the allocation of attention towards salient, reward-indicating 
stimuli, which can motivate the individual to show a particular behaviour to achieve the 
reward. With that assumption they referred to a fundamental work by Schultz and 
colleagues, who had observed that the occurrence of unexpected rewarding stimuli elicits a 
burst of spikes in dopaminergic neurons (Schultz et al., 1997). In contrast, if its appearance is 
signaled by a conditioned cue, the discharge of the dopaminergic neurons occurs already 
with the perception of the conditioned cue, and the rewarding stimulus itself does no longer 
elicit a discharge of dopamine. These results were remarkable, as Schultz and coworkers 
also showed that the absence of an expected reward after the occurrence of a conditioned 
cue leads to a transient cessation of dopamine neuron firing directly after the moment when 
the expected reward does not arrive (see Figure 2). Thus, the dopaminergic system indicates 
unexpected reward as well as the non-appearance of expected reinforcers, i.e. it serves as an 
error-detection signal and therefore contributes to learning, goal directed behaviour as well 
as behavioural flexibility. Furthermore, the dopamine signal reflects the magnitude of the 
anticipated reward (Tobler et al., 2005). Thus, the nucleus accumbens may act as a “sensory 
motor gateway” controlling the effects of salient contextual stimuli on prefrontal brain areas 
and limbic regions which regulate attention as well as motor behaviour. 
 
 Fig. 2. Reward-associated phasic dopamine release (Schulz et al., 1997). Top: Unexpected and 
unpredicted reward (banana pellets for rhesus monkeys) is reflected in a short term increase 
in dopamine firing. Middle: After having learned that a light (conditioned stimulus, CS) 
regularly predicts a reward (R), the appearance of the CS generates a short-term increase in 
phasic dopamine firing rate. The reward itself is now completely predicted by the CS and 
does not elicit dopamine firing. Bottom: If a CS is not followed by the expected reward, an 
error in reward prediction occurs (unexpected lack of reward), which is reflected in a phasic 
decrease in dopamine firing. 
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specific behavioural interventions or psychopharmacological modification of alcohol 
craving and the risk of relapse. 
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a conditioned stimulus (CS). As a consequence, this stimulus can itself provoke 
consumption or associated behavior as a conditioned response (CR; see Figure 1).  
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characterizing situations of alcohol or drug intake and their associated effects may act as 
conditioned stimuli that trigger counter-adaptive alterations in neurotransmission. Such 
changes may manifest as subjectively aversive withdrawal symptoms and lead to repeated 
drug intake, i.e. trigger relapse (Verheul et al., 1999). 
 
2.2 Reward-associated changes in salience 
If a person is repeatedly exposed to a drug or alcohol intake, different neuroadaptive 
changes are considered to happen. One important aspect is that our brains’ attentional 
network is highly effective in learning to react to contextual or internal stimuli which are of 
high relevance, i.e. of high salience. Robinson and Berridge (1993) suggested that phasic 
dopamine release facilitates the allocation of attention towards salient, reward-indicating 
stimuli, which can motivate the individual to show a particular behaviour to achieve the 
reward. With that assumption they referred to a fundamental work by Schultz and 
colleagues, who had observed that the occurrence of unexpected rewarding stimuli elicits a 
burst of spikes in dopaminergic neurons (Schultz et al., 1997). In contrast, if its appearance is 
signaled by a conditioned cue, the discharge of the dopaminergic neurons occurs already 
with the perception of the conditioned cue, and the rewarding stimulus itself does no longer 
elicit a discharge of dopamine. These results were remarkable, as Schultz and coworkers 
also showed that the absence of an expected reward after the occurrence of a conditioned 
cue leads to a transient cessation of dopamine neuron firing directly after the moment when 
the expected reward does not arrive (see Figure 2). Thus, the dopaminergic system indicates 
unexpected reward as well as the non-appearance of expected reinforcers, i.e. it serves as an 
error-detection signal and therefore contributes to learning, goal directed behaviour as well 
as behavioural flexibility. Furthermore, the dopamine signal reflects the magnitude of the 
anticipated reward (Tobler et al., 2005). Thus, the nucleus accumbens may act as a “sensory 
motor gateway” controlling the effects of salient contextual stimuli on prefrontal brain areas 
and limbic regions which regulate attention as well as motor behaviour. 
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does not elicit dopamine firing. Bottom: If a CS is not followed by the expected reward, an 
error in reward prediction occurs (unexpected lack of reward), which is reflected in a phasic 
decrease in dopamine firing. 
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In humans, few studies directly examined the correlation between cue-induced brain 
activation and dopamine dysfunction or changes in other neurotransmitter systems such as 
glutamate or GABA. Studies showed that in detoxified alcohol-dependent patients, the 
extent of alcohol craving was correlated with both a low dopamine synthesis capacity 
measured with F-DOPA PET and with a reduced availability of dopamine D2-receptors in 
the ventral striatum (Heinz et al., 2005b; Heinz et al., 2004b). This reduction was correlated 
with an increased activation of the anterior cingulate and adjacent medial prefrontal cortex 
measured with fMRI during the processing of alcohol-related versus neutral control stimuli 
(Heinz et al., 2004b). Interestingly, these brain areas have been associated with attention 
attribution to salient stimuli (Fuster et al., 1997). It seems surprising that alcohol-associated 
stimuli should provoke an increase in brain activation in attention network although all 
other contextual cues, in this case a loud and noisy MRI scanner, indicate that there is no 
chance for obtaining alcohol. One possible explanation is based on the work of Schultz and 
colleagues (1997) who demonstrated that phasic alterations in dopamine release are not only 
required to learn new stimulus-reward associations but also that they may be necessary to 
“unlearn” established associations. In this phase of dependence, low dopamine synthesis, 
reduced stimulus-induced dopamine release and diminished D2-receptor availability in the 
ventral striatum (Heinz et al., 2005b; Heinz et al., 2004b; Martinez et al., 2005) may interfere 
with dopamine-dependent processing of errors in reward expectation (Heinz et al., 2004b). 
Moving attention away from drug-associated conditioned stimuli and diminishing the 
attributed salience of such cues might be of specific difficulty for drug-dependent patients. 
Signaling of the potential availability of alcohol or the drug of abuse has been well learned, 
for example via glutamate-dependent long-term potentiation within the ventral 
hippocampus-ventral striatal pathway which has been associated with perseverative 
behaviour (Goto & Grace, 2005). In accordance with this hypothesis, a linear correlation 
between increased alcohol cue-induced activation of the medial prefrontal cortex and the 
reduction of dopamine D2-receptor availability in the ventral striatum was found in 
detoxified alcoholics, further underlining that the degree of dopamine dysfunction may 
contribute to excessive salience attribution to alcohol-associated cues (Heinz et al., 2004b). 
Also in clinical experience, many detoxified alcohol-dependent patients report difficulty to 
remain abstinent when being confronted with scenes which still are of high salience for drug 
intake, i.e. typical drinking situations like someone sitting lonely on the sofa and watching 
TV ads for an alcoholic beverage. 
Moving one step further, first studies indicate why the process of re-learning non-addictive 
behaviour seems so difficult to initiate: due to the described changes within the phasic 
characteristics of dopaminergic neurotransmission, alcohol-dependent patients may have 
problems in attributing salience to newly learned conditioned stimuli indicating the 
availability of non-drug reward. Wrase and colleagues (2007) observed a reduction in 
functional activation in the ventral striatum when being confronted with non-drug-
associated, reward-indicating cues in alcoholics. Moreover, the reduced activation was 
correlated with the severity of alcohol craving and could not be explained by performance 
differences or mood. Reduced activation of the striatum to new, reward-indicating stimuli 
might therefore reflect the patients’ diminished motivation to experience new and 
potentially rewarding situations. Interestingly, the same patients showed an increased 
activity of the ventral striatum when being confronted with alcohol-associated stimuli, 
which was also correlated with the severity of alcohol craving. Such a finding is in line with 
the prominent hypothesis that substances of abuse “hijack” the reward system and stabilize 
a dysfunctional state, i.e. when the ventrial striatum primarily responds to drug-associated 
stimuli while the adequate processing of conventional, primary reinforcing stimuli such as 
food or sex is impeded (Volkow et al., 2004). Further research is needed to elucidate 
neuronal processing of natural reinforcers in addiction as well as (reversal) learning in 
general. For clinical practice, these findings also improve our understanding why it can be 
difficult to motivate detoxified alcoholics to replace alcohol by other reinforcers such as 
social interactions or new activities: their brains’ response to alternative reward-indicating 
stimuli tends to be reduced in relevant brain regions. This may make it very difficult to - 
literally spoken - concentrate oneself on other aspects of the world than cues associated with 
the drug of abuse. 
 
2.3 Modification in emotional response 
One milestone of neurobiological research on alcohol and drug addiction is the observation 
that alcohol and all other drugs of abuse induce dopamine release in the ventral striatum, 
including the nucleus accumbens, and thus reinforce drug intake (Wise, 1988). Although a 
drug thus “reinforces” a specific behaviour, this does not necessarily imply that the drug 
effect is also subjectively pleasant. In a commonly known work by Robinson and Berridge 
(1993) the authors suggested to distinguish between the hedonic, i.e. pleasant, drug effects 
(“liking”) and the feeling of craving for such a positive effect (“wanting”). Further, they 
attributed these effects to different neurotransmitter systems. They suggested that 
neurobiological effects associated with “liking” the drug are mediated by opioidergic 
neurotransmission in the ventral striatum, including the nucleus accumbens. This 
assumption was based on the observation that hedonic effects during consumption of a 
drug are caused by endorphin release in these brain areas – like during the consumption of 
primarily reinforcing stimuli such as food (Berridge & Robinson, 1998). Based on the work 
of Schultz and colleagues (1997), Berridge and Robinson further suggested that the 
neurobiological correlate of “wanting” is (phasic) dopamine release in the ventral striatum. 
Following imaging studies intended to evaluate these aspects of the reward system - on a 
neurobiological as well as on a behavioural level by additionally using questionnaires for 
drug craving as a proxy for “wanting” beside scales measuring pleasure as a proxy for 
“liking”. Indeed, studies suggested that acute drug craving is associated with dopamine 
dysfunction in the ventral striatum, i.e. reduced dopamine synthesis and D2-receptor 
availability (Heinz et al., 2005b), while increased μ-opiate receptors in the ventral striatum 
correlated with other aspects of chronic alcohol intake and alcohol urges (Heinz et al., 
2005a). 
 
2.4 Memory formation 
Striatal dopamine release is regulated by the hippocampus, which is well known to play a 
major role in memory formation (Lisman & Grace, 2005). In rats that had formerly 
consumed cocaine, the stimulation of glutamatergic neurons in the hippocampus resulted in 
dopamine release in the ventral striatum and led to renewed drug intake (Vorel et al., 2001). 
Experimental stimulation of the hippocampus may reflect real-life situations in which 
contextual, drug-associated cues activate the hippocampus and thus trigger memories 
associated with previous drug use (see Figure 3). In such situations, the activation of the 
www.intechopen.com
Neurobiology of substance-related addiction: indings of neuroimaging 97
In humans, few studies directly examined the correlation between cue-induced brain 
activation and dopamine dysfunction or changes in other neurotransmitter systems such as 
glutamate or GABA. Studies showed that in detoxified alcohol-dependent patients, the 
extent of alcohol craving was correlated with both a low dopamine synthesis capacity 
measured with F-DOPA PET and with a reduced availability of dopamine D2-receptors in 
the ventral striatum (Heinz et al., 2005b; Heinz et al., 2004b). This reduction was correlated 
with an increased activation of the anterior cingulate and adjacent medial prefrontal cortex 
measured with fMRI during the processing of alcohol-related versus neutral control stimuli 
(Heinz et al., 2004b). Interestingly, these brain areas have been associated with attention 
attribution to salient stimuli (Fuster et al., 1997). It seems surprising that alcohol-associated 
stimuli should provoke an increase in brain activation in attention network although all 
other contextual cues, in this case a loud and noisy MRI scanner, indicate that there is no 
chance for obtaining alcohol. One possible explanation is based on the work of Schultz and 
colleagues (1997) who demonstrated that phasic alterations in dopamine release are not only 
required to learn new stimulus-reward associations but also that they may be necessary to 
“unlearn” established associations. In this phase of dependence, low dopamine synthesis, 
reduced stimulus-induced dopamine release and diminished D2-receptor availability in the 
ventral striatum (Heinz et al., 2005b; Heinz et al., 2004b; Martinez et al., 2005) may interfere 
with dopamine-dependent processing of errors in reward expectation (Heinz et al., 2004b). 
Moving attention away from drug-associated conditioned stimuli and diminishing the 
attributed salience of such cues might be of specific difficulty for drug-dependent patients. 
Signaling of the potential availability of alcohol or the drug of abuse has been well learned, 
for example via glutamate-dependent long-term potentiation within the ventral 
hippocampus-ventral striatal pathway which has been associated with perseverative 
behaviour (Goto & Grace, 2005). In accordance with this hypothesis, a linear correlation 
between increased alcohol cue-induced activation of the medial prefrontal cortex and the 
reduction of dopamine D2-receptor availability in the ventral striatum was found in 
detoxified alcoholics, further underlining that the degree of dopamine dysfunction may 
contribute to excessive salience attribution to alcohol-associated cues (Heinz et al., 2004b). 
Also in clinical experience, many detoxified alcohol-dependent patients report difficulty to 
remain abstinent when being confronted with scenes which still are of high salience for drug 
intake, i.e. typical drinking situations like someone sitting lonely on the sofa and watching 
TV ads for an alcoholic beverage. 
Moving one step further, first studies indicate why the process of re-learning non-addictive 
behaviour seems so difficult to initiate: due to the described changes within the phasic 
characteristics of dopaminergic neurotransmission, alcohol-dependent patients may have 
problems in attributing salience to newly learned conditioned stimuli indicating the 
availability of non-drug reward. Wrase and colleagues (2007) observed a reduction in 
functional activation in the ventral striatum when being confronted with non-drug-
associated, reward-indicating cues in alcoholics. Moreover, the reduced activation was 
correlated with the severity of alcohol craving and could not be explained by performance 
differences or mood. Reduced activation of the striatum to new, reward-indicating stimuli 
might therefore reflect the patients’ diminished motivation to experience new and 
potentially rewarding situations. Interestingly, the same patients showed an increased 
activity of the ventral striatum when being confronted with alcohol-associated stimuli, 
which was also correlated with the severity of alcohol craving. Such a finding is in line with 
the prominent hypothesis that substances of abuse “hijack” the reward system and stabilize 
a dysfunctional state, i.e. when the ventrial striatum primarily responds to drug-associated 
stimuli while the adequate processing of conventional, primary reinforcing stimuli such as 
food or sex is impeded (Volkow et al., 2004). Further research is needed to elucidate 
neuronal processing of natural reinforcers in addiction as well as (reversal) learning in 
general. For clinical practice, these findings also improve our understanding why it can be 
difficult to motivate detoxified alcoholics to replace alcohol by other reinforcers such as 
social interactions or new activities: their brains’ response to alternative reward-indicating 
stimuli tends to be reduced in relevant brain regions. This may make it very difficult to - 
literally spoken - concentrate oneself on other aspects of the world than cues associated with 
the drug of abuse. 
 
2.3 Modification in emotional response 
One milestone of neurobiological research on alcohol and drug addiction is the observation 
that alcohol and all other drugs of abuse induce dopamine release in the ventral striatum, 
including the nucleus accumbens, and thus reinforce drug intake (Wise, 1988). Although a 
drug thus “reinforces” a specific behaviour, this does not necessarily imply that the drug 
effect is also subjectively pleasant. In a commonly known work by Robinson and Berridge 
(1993) the authors suggested to distinguish between the hedonic, i.e. pleasant, drug effects 
(“liking”) and the feeling of craving for such a positive effect (“wanting”). Further, they 
attributed these effects to different neurotransmitter systems. They suggested that 
neurobiological effects associated with “liking” the drug are mediated by opioidergic 
neurotransmission in the ventral striatum, including the nucleus accumbens. This 
assumption was based on the observation that hedonic effects during consumption of a 
drug are caused by endorphin release in these brain areas – like during the consumption of 
primarily reinforcing stimuli such as food (Berridge & Robinson, 1998). Based on the work 
of Schultz and colleagues (1997), Berridge and Robinson further suggested that the 
neurobiological correlate of “wanting” is (phasic) dopamine release in the ventral striatum. 
Following imaging studies intended to evaluate these aspects of the reward system - on a 
neurobiological as well as on a behavioural level by additionally using questionnaires for 
drug craving as a proxy for “wanting” beside scales measuring pleasure as a proxy for 
“liking”. Indeed, studies suggested that acute drug craving is associated with dopamine 
dysfunction in the ventral striatum, i.e. reduced dopamine synthesis and D2-receptor 
availability (Heinz et al., 2005b), while increased μ-opiate receptors in the ventral striatum 
correlated with other aspects of chronic alcohol intake and alcohol urges (Heinz et al., 
2005a). 
 
2.4 Memory formation 
Striatal dopamine release is regulated by the hippocampus, which is well known to play a 
major role in memory formation (Lisman & Grace, 2005). In rats that had formerly 
consumed cocaine, the stimulation of glutamatergic neurons in the hippocampus resulted in 
dopamine release in the ventral striatum and led to renewed drug intake (Vorel et al., 2001). 
Experimental stimulation of the hippocampus may reflect real-life situations in which 
contextual, drug-associated cues activate the hippocampus and thus trigger memories 
associated with previous drug use (see Figure 3). In such situations, the activation of the 
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described hippocampus-VTA circuit will activate dopamine neurons in the VTA, which 
elicit dopamine release in the ventral striatum, thus facilitating new drug intake (Floresco et 
al., 2001). Indeed it has been shown that both cocaine and amphetamine sensitization (Goto 
& Grace, 2005; Lodge & Grace, 2008) increases hippocampal input in the nucleus 
accumbens, finally resulting in aggravated responses of the dopaminergic system. 
Hyman (2005) argued that addiction somehow represents neuroadaptive processes in 
learning and memory that - under normal circumstances - serve to shape survival 
behaviour, i.e. behaviour related to the pursuit of rewards and the cues that predict them. 
Beside the possibility of synapse elimination and remodelling, the best known mechanisms 
of synaptic plasticity in learning and memory are such phenomena that change the strength 
or “weight” of existing connections, so called long-term potentiation and long-term 
depression. Although most of relevant research is based on animal models, long-term 
potentiation and depression have become important candidate mechanisms for the drug-
induced alterations of neural circuits that are posited to occur with addiction in humans. 
There is evidence that both mechanisms occur in the nucleus accumbens and other targets of 
mesolimbic dopamine neurons as a consequence of drug administration, and growing 
literature suggests that they may play an important role in the development of addiction. 
The underlying molecular mechanisms include regulation of the phosphorylation state of 
key proteins, alterations in the availability of glutamate receptors at the synapse and 
regulation of gene expression (for review see e.g. Hyman & Malenka, 2001; Kauer et al., 
2004; Thomas & Malenka, 2003). 
 
 Fig. 3. A model of reward prediction in the brain: discrepancies between the expected and 
actual sensory input are recognized in the hippocampus. This activates dopaminergic 
neurons in the ventral tegmental area (VTA) via glutamatergic projections to the nucleus 
accumbens (Nac, incl. ventral striatum). The VTA in turn modulates neuronal transmission 
in CA1 region of the hippocampus via an increased dopamine-release and thus contributes 
to memory modification. The prefrontal cortex contributes to executive control functions 
and modulates the firing rate of dopaminergic neurons that project from the VTA region to 
the Nac and the amygdala (modified from Lisman & Grace, 2005). 
3. Developing addiction 
3.1 Criteria of addiction 
Alcohol dependence and other drug addictions are characterized by criteria such as 
tolerance development, withdrawal symptoms, drug craving and reduced control of drug 
intake (American Psychiatric Association, 2000; World Health Organization, 2007). For the 
development of tolerance, it has been suggested that this phenomenon is based on a process 
of neuroadaptation in the brain to chronically increased alcohol or drug consumption. 
Continued drug intake leads to an anticipatory compensation of the drugs’ effects by the 
brain, which results in a new homeostatic balance. This adapted state of equilibrium is 
disturbed when drug or alcohol intake is suddenly interrupted, as it is the case during 
detoxification. This can result in clinically manifest withdrawal symptoms, which are 
opposed to the drugs primary physiological and psychological effects (Koob, 2003). For 
instance, alcohols’ sedative effects are mediated by inhibition of glutamatergic and 
stimulation of GABAergic neurotransmission (Tsai et al., 1995; Krystal et al., 2006). 
Insufficient GABAergic inhibition and increased glutamatergic excitation may result in 
highly aversive withdrawal symptoms and in epileptic seizures (Tsai et al., 1995; Krystal et 
al., 2006). Many imaging studies have focused on the neurobiological correlates of the 
defining characteristics of addiction in order to gain insight into the essence of the disease. 
 
3.2 Craving 
Within cue-reactivity paradigms, the reported correlations between subjectively reported 
craving and the actual consumptive behaviour are often low. This may in parts be explained 
by the different levels the reaction can emerge on (subjective, motor, physiological) and 
which are associated with different degrees of consciousness. Tiffany (1990) described a 
cognitive model in which conscious craving only occurs if an automatic process of drug 
intake is interrupted, which may be triggered by conditioned stimuli and motivate for drug 
intake even in the absence of conscious drug urges. 
Unfortunately, imaging results regarding cue-induced activity in the brain and subjective 
craving for alcohol or other drugs are not very consistent. Myrick and colleagues (2004) 
reported an association between the severity of craving and functional brain activation in 
the ventral striatum, orbitofrontal cortex and anterior cingulate cortex, while others 
described such a relationship for the dorsal striatum (Modell & Mountz, 1995) or the 
subcallosal gyrus (Tapert et al., 2004). Further studies were not able to identify any 
significant correlation between alcohol craving and cue-induced brain activation (Grüsser et 
al., 2004; Heinz et al., 2004b). Trying to understand these diverging findings, one has to take 
into account that all studies used different stimuli for craving induction: alcohol-related 
words (Tapert et al., 2004), alcohol-related pictures with (Myrick et al., 2004) or without 
(Grüsser et al., 2004) a sip of alcohol (“priming dose”). Furthermore, time point of 
examination differed from patients being not detoxified (Myrick et al., 2004) to detoxified 
patients in an inpatient treatment program (Braus et al., 2001; Grüsser et al., 2004; Heinz et 
al., 2004b; Heinz et al., 2007; Wrase et al., 2002; Wrase et al., 2007). 
 
3.3 Habit formation 
For the development of addiction, specifically for reduced control of drug intake, it is of 
high relevance (Robbins & Everitt, 2002) to understand the behavioural transfer from 
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described hippocampus-VTA circuit will activate dopamine neurons in the VTA, which 
elicit dopamine release in the ventral striatum, thus facilitating new drug intake (Floresco et 
al., 2001). Indeed it has been shown that both cocaine and amphetamine sensitization (Goto 
& Grace, 2005; Lodge & Grace, 2008) increases hippocampal input in the nucleus 
accumbens, finally resulting in aggravated responses of the dopaminergic system. 
Hyman (2005) argued that addiction somehow represents neuroadaptive processes in 
learning and memory that - under normal circumstances - serve to shape survival 
behaviour, i.e. behaviour related to the pursuit of rewards and the cues that predict them. 
Beside the possibility of synapse elimination and remodelling, the best known mechanisms 
of synaptic plasticity in learning and memory are such phenomena that change the strength 
or “weight” of existing connections, so called long-term potentiation and long-term 
depression. Although most of relevant research is based on animal models, long-term 
potentiation and depression have become important candidate mechanisms for the drug-
induced alterations of neural circuits that are posited to occur with addiction in humans. 
There is evidence that both mechanisms occur in the nucleus accumbens and other targets of 
mesolimbic dopamine neurons as a consequence of drug administration, and growing 
literature suggests that they may play an important role in the development of addiction. 
The underlying molecular mechanisms include regulation of the phosphorylation state of 
key proteins, alterations in the availability of glutamate receptors at the synapse and 
regulation of gene expression (for review see e.g. Hyman & Malenka, 2001; Kauer et al., 
2004; Thomas & Malenka, 2003). 
 
 Fig. 3. A model of reward prediction in the brain: discrepancies between the expected and 
actual sensory input are recognized in the hippocampus. This activates dopaminergic 
neurons in the ventral tegmental area (VTA) via glutamatergic projections to the nucleus 
accumbens (Nac, incl. ventral striatum). The VTA in turn modulates neuronal transmission 
in CA1 region of the hippocampus via an increased dopamine-release and thus contributes 
to memory modification. The prefrontal cortex contributes to executive control functions 
and modulates the firing rate of dopaminergic neurons that project from the VTA region to 
the Nac and the amygdala (modified from Lisman & Grace, 2005). 
3. Developing addiction 
3.1 Criteria of addiction 
Alcohol dependence and other drug addictions are characterized by criteria such as 
tolerance development, withdrawal symptoms, drug craving and reduced control of drug 
intake (American Psychiatric Association, 2000; World Health Organization, 2007). For the 
development of tolerance, it has been suggested that this phenomenon is based on a process 
of neuroadaptation in the brain to chronically increased alcohol or drug consumption. 
Continued drug intake leads to an anticipatory compensation of the drugs’ effects by the 
brain, which results in a new homeostatic balance. This adapted state of equilibrium is 
disturbed when drug or alcohol intake is suddenly interrupted, as it is the case during 
detoxification. This can result in clinically manifest withdrawal symptoms, which are 
opposed to the drugs primary physiological and psychological effects (Koob, 2003). For 
instance, alcohols’ sedative effects are mediated by inhibition of glutamatergic and 
stimulation of GABAergic neurotransmission (Tsai et al., 1995; Krystal et al., 2006). 
Insufficient GABAergic inhibition and increased glutamatergic excitation may result in 
highly aversive withdrawal symptoms and in epileptic seizures (Tsai et al., 1995; Krystal et 
al., 2006). Many imaging studies have focused on the neurobiological correlates of the 
defining characteristics of addiction in order to gain insight into the essence of the disease. 
 
3.2 Craving 
Within cue-reactivity paradigms, the reported correlations between subjectively reported 
craving and the actual consumptive behaviour are often low. This may in parts be explained 
by the different levels the reaction can emerge on (subjective, motor, physiological) and 
which are associated with different degrees of consciousness. Tiffany (1990) described a 
cognitive model in which conscious craving only occurs if an automatic process of drug 
intake is interrupted, which may be triggered by conditioned stimuli and motivate for drug 
intake even in the absence of conscious drug urges. 
Unfortunately, imaging results regarding cue-induced activity in the brain and subjective 
craving for alcohol or other drugs are not very consistent. Myrick and colleagues (2004) 
reported an association between the severity of craving and functional brain activation in 
the ventral striatum, orbitofrontal cortex and anterior cingulate cortex, while others 
described such a relationship for the dorsal striatum (Modell & Mountz, 1995) or the 
subcallosal gyrus (Tapert et al., 2004). Further studies were not able to identify any 
significant correlation between alcohol craving and cue-induced brain activation (Grüsser et 
al., 2004; Heinz et al., 2004b). Trying to understand these diverging findings, one has to take 
into account that all studies used different stimuli for craving induction: alcohol-related 
words (Tapert et al., 2004), alcohol-related pictures with (Myrick et al., 2004) or without 
(Grüsser et al., 2004) a sip of alcohol (“priming dose”). Furthermore, time point of 
examination differed from patients being not detoxified (Myrick et al., 2004) to detoxified 
patients in an inpatient treatment program (Braus et al., 2001; Grüsser et al., 2004; Heinz et 
al., 2004b; Heinz et al., 2007; Wrase et al., 2002; Wrase et al., 2007). 
 
3.3 Habit formation 
For the development of addiction, specifically for reduced control of drug intake, it is of 
high relevance (Robbins & Everitt, 2002) to understand the behavioural transfer from 
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conscious consumption to a more automated behaviour, i.e. forming a habit (Tiffany, 1990). 
It has been suggested that the dorsal striatum is crucial for habit learning, i.e. for the 
learning of automated responses, and may thus contribute to the compulsive character of 
dependent behaviour. 
The importance of habitual drug intake for the development of addiction appears to be 
reflected in anatomical changes associated with cue-induced activation: whilst reward-
driven striatal reactivity is known to predominantly involve the ventral striatum, cue-
induced conscious craving in addicted subjects may preferentially elicit dopamine release in 
more dorsal striatal structures (Volkow et al., 2006; Wong et al., 2006). Such a transition from 
a predominantly ventral response to the dorsal striatum might reflect a change from a 
reward-driven activity of the ventral striatum to a more automated stimulus-response habit 
formation depending on dorsal striatal activity (Berke & Hyman, 2000). The rewarding 
effect of e.g. ventral striatal dopamine release may play a subordinate role in such 
automated processes, what is in line with the clinical impression and reports of patients. In 
accordance, Robbins and Everitt (2002) proposed that the initially reinforcing effect of drugs 
of abuse is based on the activation of the ventral striatum, while the transfer into habitual 
drug-seeking is associated with activation of more dorsal striatal regions. Studies with PET 
could also support that assumption, since among addicted subjects, drug cues preferentially 
lead to dopamine release in the dorsal striatum and putamen (Volkow et al., 2006; Wong et 
al., 2006). In line with the research, many patients also describe their relapse in terms of 
automated actions and do not remember to have experienced craving before relapse as in 
earlier stages of disease development (Tiffany, 1990). 
 
3.4 Neurochemical adaptation underlying the development of addiction 
Different neurotransmitter systems are involved in the processing of rewarding stimuli in 
general and of addiction-related phenomena in particular (see 1.3. for an overview). For a 
long time, neurobiological research on addiction mainly focussed on dopamine 
dysfunctions but in the recent past it has broaden its view on other neurotransmitter 
systems. 
Brain imaging studies with PET clearly showed a reduced availability and sensitivity of 
central dopamine D2-receptors in alcohol-dependent patients – potentially reflecting a 
compensatory down-regulation after chronic alcohol intake, which was associated with the 
subsequent relapse risk (Heinz et al., 1996; Volkow et al., 1996). Following PET studies (F-
DOPA PET) revealed that alcohol craving was specifically correlated with a low dopamine 
synthesis capacity and with reduced dopamine D2-receptor availability in the ventral 
striatum including the nucleus accumbens (Heinz et al., 2004b; Heinz et al., 2005b). Animal 
experiments also showed that extracellular dopamine concentrations decreased rapidly 
during detoxification (Rossetti et al., 1992). Thus, dopamine dysfunction may further be 
augmented by reduced intra-synaptic dopamine release during early abstinence. Another 
PET study (Martinez et al., 2005) showed that dopamine release in detoxified alcoholics was 
significantly reduced following amphetamine administration. Thus, overall dopaminergic 
neurotransmission in the ventral striatum of alcohol-dependent patients was reduced after 
detoxification. Unlike suggested by Robinson and Berridge (1993), it thus might seem 
unlikely that the appearance of a drug-associated cue can cause a significant dopamine 
release triggering craving or relapse. Indeed, animal studies demonstrated that alcohol and 
drug-associated stimuli can lead to relapse even if no dopamine is released in the ventral 
striatum (Shalev et al., 2002). Nevertheless, a down-regulation rather than a sensitisation of 
the dopamine system appears to play a role in relapse behaviour: In humans, dopamine 
dysfunction was correlated with the severity of alcohol craving and with increased 
processing of alcohol-associated cues in the anterior cingulate and medial prefrontal cortex 
(Heinz et al., 2004b), brain areas in which an increased reaction on alcohol cues has been 
associated with an increased relapse risk (Grüsser et al., 2004). 
Structural changes in striatal GABAergic neurons have also been considered to account for 
phenomena of long-term sensitisation towards the effects of drugs and drug-associated 
stimuli. Striatal GABAergic neurons are innervated by dopaminergic neurons and play a 
major role in the signal transfer towards the thalamus and the cortex (Robinson and Kolb, 
1997). E.g., alcohol consumption stimulates GABA receptors and inhibits the function of 
glutamatergic NMDA-receptors (Kalivas & Volkow, 2005; Krystal et al., 2006). The alcohol-
induced inhibition of the glutamatergic signal transduction results in up-regulation of 
NMDA receptors (Schumann et al., 2005; Tsai et al., 1995). As a consequence, the loss of this 
inhibition of NMDA receptor function via alcohol during early abstinence was related to 
hyperexcitation and withdrawal symptoms (Spanagel, 2003). Repeated withdrawal in turn 
elicits an increase in glutamate release (Kalivas et al., 2005). Therefore, it has been suggested 
that glutamatergic neurotransmission in a brain network spanning the prefrontal cortex, the 
amygdala, the hippocampus, the nucleus accumbens and the ventral tegmental area plays a 
major role in triggering relapse (Kalivas et al., 2005). Pharmacological treatment strategies 
pick up such findings, e.g. acamprosate, a drug used to reduce relapse risk in alcohol-
dependent patients, diminishes alcohol craving via modulation of NMDA-receptors (Mann 
et al., 2004; Spanagel, 2003). 
As already noted, the cannabinoid and opioidergic system also play a role in the 
development and maintenance of addictive behaviour. High concentration of CB1-receptors 
have been described in relevant brain regions, in detail in the prefrontal cortex, the 
amygdala, the ventral tegmental area, the hippocampus, the nucleus accumbens and the 
ventral striatum. In animal models of excessive nicotine and methamphetamine abuse, 
blockade of CB1-receptors reduced drug intake during relapse (De Vries & Schoffelmeer, 
2005). Therefore, CB1-receptors are thought to modulate the activity of other 
neurotransmitters (dopamine, GABA and glutamate) and elicit long-term changes in 
synaptic transmission, in detail long-term potentiation or depression. Anyhow, further 
research is needed here to elicit the complex interplay of these neurotransmitter systems.  
Within the opioidergic system, animal studies showed that blockade of μ-opiate receptors 
with naltrexone reduced dopamine release in the ventral striatum as well as alcohol 
consumption (Gonzales & Weiss, 1998). In humans, it has been shown that alcohol-
dependent patients display an increase of μ-opiate receptors in the ventral striatum, which 
was further significantly correlated with the amount of craving (Heinz et al., 2005a). In line 
with that, application of the opiate antagonist naltrexone in humans can reduce alcohol 
craving and the subjective “liking” of the drug associated with its intake (O’Brien, 2005) and 
might reduce the risk of relapse in some patients (e.g. Srisurapanont & Jarusuraisin, 2005). 
 
4. Risk of relapse 
Detoxification itself does little to prevent subsequent relapse in alcoholics. Up to 85% of all 
patients relapse in the placebo control groups of treatment studies, even if treated as 
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conscious consumption to a more automated behaviour, i.e. forming a habit (Tiffany, 1990). 
It has been suggested that the dorsal striatum is crucial for habit learning, i.e. for the 
learning of automated responses, and may thus contribute to the compulsive character of 
dependent behaviour. 
The importance of habitual drug intake for the development of addiction appears to be 
reflected in anatomical changes associated with cue-induced activation: whilst reward-
driven striatal reactivity is known to predominantly involve the ventral striatum, cue-
induced conscious craving in addicted subjects may preferentially elicit dopamine release in 
more dorsal striatal structures (Volkow et al., 2006; Wong et al., 2006). Such a transition from 
a predominantly ventral response to the dorsal striatum might reflect a change from a 
reward-driven activity of the ventral striatum to a more automated stimulus-response habit 
formation depending on dorsal striatal activity (Berke & Hyman, 2000). The rewarding 
effect of e.g. ventral striatal dopamine release may play a subordinate role in such 
automated processes, what is in line with the clinical impression and reports of patients. In 
accordance, Robbins and Everitt (2002) proposed that the initially reinforcing effect of drugs 
of abuse is based on the activation of the ventral striatum, while the transfer into habitual 
drug-seeking is associated with activation of more dorsal striatal regions. Studies with PET 
could also support that assumption, since among addicted subjects, drug cues preferentially 
lead to dopamine release in the dorsal striatum and putamen (Volkow et al., 2006; Wong et 
al., 2006). In line with the research, many patients also describe their relapse in terms of 
automated actions and do not remember to have experienced craving before relapse as in 
earlier stages of disease development (Tiffany, 1990). 
 
3.4 Neurochemical adaptation underlying the development of addiction 
Different neurotransmitter systems are involved in the processing of rewarding stimuli in 
general and of addiction-related phenomena in particular (see 1.3. for an overview). For a 
long time, neurobiological research on addiction mainly focussed on dopamine 
dysfunctions but in the recent past it has broaden its view on other neurotransmitter 
systems. 
Brain imaging studies with PET clearly showed a reduced availability and sensitivity of 
central dopamine D2-receptors in alcohol-dependent patients – potentially reflecting a 
compensatory down-regulation after chronic alcohol intake, which was associated with the 
subsequent relapse risk (Heinz et al., 1996; Volkow et al., 1996). Following PET studies (F-
DOPA PET) revealed that alcohol craving was specifically correlated with a low dopamine 
synthesis capacity and with reduced dopamine D2-receptor availability in the ventral 
striatum including the nucleus accumbens (Heinz et al., 2004b; Heinz et al., 2005b). Animal 
experiments also showed that extracellular dopamine concentrations decreased rapidly 
during detoxification (Rossetti et al., 1992). Thus, dopamine dysfunction may further be 
augmented by reduced intra-synaptic dopamine release during early abstinence. Another 
PET study (Martinez et al., 2005) showed that dopamine release in detoxified alcoholics was 
significantly reduced following amphetamine administration. Thus, overall dopaminergic 
neurotransmission in the ventral striatum of alcohol-dependent patients was reduced after 
detoxification. Unlike suggested by Robinson and Berridge (1993), it thus might seem 
unlikely that the appearance of a drug-associated cue can cause a significant dopamine 
release triggering craving or relapse. Indeed, animal studies demonstrated that alcohol and 
drug-associated stimuli can lead to relapse even if no dopamine is released in the ventral 
striatum (Shalev et al., 2002). Nevertheless, a down-regulation rather than a sensitisation of 
the dopamine system appears to play a role in relapse behaviour: In humans, dopamine 
dysfunction was correlated with the severity of alcohol craving and with increased 
processing of alcohol-associated cues in the anterior cingulate and medial prefrontal cortex 
(Heinz et al., 2004b), brain areas in which an increased reaction on alcohol cues has been 
associated with an increased relapse risk (Grüsser et al., 2004). 
Structural changes in striatal GABAergic neurons have also been considered to account for 
phenomena of long-term sensitisation towards the effects of drugs and drug-associated 
stimuli. Striatal GABAergic neurons are innervated by dopaminergic neurons and play a 
major role in the signal transfer towards the thalamus and the cortex (Robinson and Kolb, 
1997). E.g., alcohol consumption stimulates GABA receptors and inhibits the function of 
glutamatergic NMDA-receptors (Kalivas & Volkow, 2005; Krystal et al., 2006). The alcohol-
induced inhibition of the glutamatergic signal transduction results in up-regulation of 
NMDA receptors (Schumann et al., 2005; Tsai et al., 1995). As a consequence, the loss of this 
inhibition of NMDA receptor function via alcohol during early abstinence was related to 
hyperexcitation and withdrawal symptoms (Spanagel, 2003). Repeated withdrawal in turn 
elicits an increase in glutamate release (Kalivas et al., 2005). Therefore, it has been suggested 
that glutamatergic neurotransmission in a brain network spanning the prefrontal cortex, the 
amygdala, the hippocampus, the nucleus accumbens and the ventral tegmental area plays a 
major role in triggering relapse (Kalivas et al., 2005). Pharmacological treatment strategies 
pick up such findings, e.g. acamprosate, a drug used to reduce relapse risk in alcohol-
dependent patients, diminishes alcohol craving via modulation of NMDA-receptors (Mann 
et al., 2004; Spanagel, 2003). 
As already noted, the cannabinoid and opioidergic system also play a role in the 
development and maintenance of addictive behaviour. High concentration of CB1-receptors 
have been described in relevant brain regions, in detail in the prefrontal cortex, the 
amygdala, the ventral tegmental area, the hippocampus, the nucleus accumbens and the 
ventral striatum. In animal models of excessive nicotine and methamphetamine abuse, 
blockade of CB1-receptors reduced drug intake during relapse (De Vries & Schoffelmeer, 
2005). Therefore, CB1-receptors are thought to modulate the activity of other 
neurotransmitters (dopamine, GABA and glutamate) and elicit long-term changes in 
synaptic transmission, in detail long-term potentiation or depression. Anyhow, further 
research is needed here to elicit the complex interplay of these neurotransmitter systems.  
Within the opioidergic system, animal studies showed that blockade of μ-opiate receptors 
with naltrexone reduced dopamine release in the ventral striatum as well as alcohol 
consumption (Gonzales & Weiss, 1998). In humans, it has been shown that alcohol-
dependent patients display an increase of μ-opiate receptors in the ventral striatum, which 
was further significantly correlated with the amount of craving (Heinz et al., 2005a). In line 
with that, application of the opiate antagonist naltrexone in humans can reduce alcohol 
craving and the subjective “liking” of the drug associated with its intake (O’Brien, 2005) and 
might reduce the risk of relapse in some patients (e.g. Srisurapanont & Jarusuraisin, 2005). 
 
4. Risk of relapse 
Detoxification itself does little to prevent subsequent relapse in alcoholics. Up to 85% of all 
patients relapse in the placebo control groups of treatment studies, even if treated as 
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inpatients until complete remission of physical withdrawal symptoms (Boothby & Doering, 
2005). It has been suggested that exposure to stress and to priming doses of alcohol can 
induce a relapse (Adinoff, 2004; Breese et al., 2005; Cooney, 1997). Another relevant 
mechanism that contributes to the risk of relapse is the exposure to stimuli that have 
regularly been associated with alcohol intake (contextual cues). Such stimuli have become 
conditioned cues that can elicit conditioned responses such as alcohol or drug craving and 
consumption behaviour (Adinoff, 2004; Berridge & Robinson, 1998; Di Chiara & Bassareo, 
2007; Everitt & Robbins 2005). In such situations, patients may experience craving for 
alcohol or the specific drug, which is based on the natural tendency to avoid unpleasant 
experiences, e.g. a conditioned withdrawal response to the presentation of drug cues in the 
absence of drug intake. Indeed, about one third of all alcoholics in a clinical setting 
described that their relapse was preceded by a sudden manifestation of withdrawal. It often 
occurred long after acute detoxification and was often triggered by “typical” drinking 
situations (Heinz et al., 2003). 
Although some imaging studies investigated the association between brain activation 
elicited by alcohol-associated stimuli and alcohol craving (see also 3.2), only few studies 
assessed to what extent cue-induced brain activation can predict the prospective relapse risk 
and therefore the clinical relevance of such imaging studies. Braus and colleagues (2001) 
reported that alcohol cues elicited increased activation of the ventral striatum and visual 
association cortices in detoxified alcoholics, and that patients who had experienced multiple 
relapses in the past showed a stronger cue-induced activity in the ventral striatum than 
patients who successfully abstained from alcohol for longer periods of time. This result was 
confirmed by Grüsser and colleagues (2004), who compared subsequently relapsing with 
abstaining patients. The latter group showed less brain activation elicited by visual alcohol-
associated stimuli in the anterior cingulate cortex, the adjacent ventral and medial prefrontal 
cortex and central parts of the striatum. As the striatum, mainly the dorsal part, has been 
suggested to be crucial for habit learning, this result might reflect differences in the habitual 
character of addictive behaviour between abstaining and relapsing patients, even in the 
absence of conscious drug urges (“craving”). These observations are in the line with studies 
in animals, in which cue-induced relapse after cocaine consumption was prevented by 
blockade of dopamine and AMPA glutamate receptors in the dorsal striatum 
(Vanderschuren et al., 2005). Thus, when talking about relapse risk, it seems to be of 
importance to distinguish between the neuronal correlates of habitual drug intake (i.e. 
without conscious craving) and drug-intake following the subjective feeling of craving. 
Unfortunately, the empirical basis for coherence between craving for the substance of abuse 
and risk of relapse is not fully satisfying. Although animal models strongly support the 
hypothesis that conditioned drug reactions are involved in the development and 
maintenance of addictive behaviour as well as relapse (Di Chiara, 2002; Robbins &Everitt, 
2002; Robinson & Berridge, 1993), studies in humans are rather heterogeneous. While some 
studies did not find a positive correlation between subjective i.e. conscious craving and 
relapse (Drummond & Glautier, 1994; Grüsser et al., 2004; Junghanns et al., 2005; Kiefer et 
al., 2005; Litt et al., 2000; Rohsenow et al., 1994), others did show significant correlations 
(Bottlender & Soyka, 2004; Cooney et al., 1997; Heinz et al., 2005b; Ludwig & Wikler, 1974; 
Monti et al., 1990). In contrast, changes in physiological parameters, including neuronal 
activation measured with functional imaging, seem to be more closely connected to relapse 
(Abrams et al., 1988; Braus et al., 2001; Drummond & Glautier, 1994; Grüsser et al., 2004; 
Rohsenow et al., 1994). Linking relapse risk with physiological responses may therefore be a 
more promising approach, and was used in several studies. 
To measure the effects of reactions to non-alcoholic, affectively positive and negative stimuli 
on the relapse risk, Heinz and colleagues (2007) briefly presented affective pictures to 
alcoholics versus control subjects while conducting fMRI measurements. The affectively 
positive pictures elicited increased brain activation in alcoholics in ventral striatum, which 
was negatively correlated with the subsequent relapse risk and may represent a protective 
factor against relapse. 
Dysfunctions of brain areas associated with executive control of behaviour (see also Figure 
3) may also contribute to relapse risk. Indeed, in methamphetamine-dependent patients, the 
subsequent relapse risk was predicted by activation patterns elicited during a two-choice 
decision-making task in the insula, posterior cingulate and temporal cortex (Paulus et al., 
2005). Similarly, Brewer and colleagues (2008) reported in cocaine dependent patients 
undergoing a stroop task an increased activation in regions relevant for cognitive control, 
including the anterior cingulate cortex, dorsolateral prefrontal cortex, as well as in the 
parietal lobule, insula and striatum. Longer duration of self-reported abstinence correlated 
with the strength of the activation of the ventromedial prefrontal cortex, left posterior 
cingulate cortex, and right striatum, percent drug-free urine screenings correlated with 
striatal activation, and treatment retention correlated with diminished activation of 
dorsolateral prefrontal cortex. Despite these promising examples, to date only few imaging 
studied followed the approach to predict relapse risk from the activity of brain areas 
associated with executive control of behaviour. 
 
5. Clinical implications 
Previous research in addiction suggests different therapeutic consequences. First of all, 
functional imaging studies help to understand the course of addiction development from its 
beginning up to its manifest state. Further, it can help to identify patients who are 
particularly at risk to relapse. As the described imaging techniques such as fMRI and PET 
are rather expensive, the transmission of these results on the application of less complicated 
techniques, which assess physiological responses to drug-associated cues, might be useful, 
e.g. the affect-modulated startle response (Heinz et al., 2003). Physiological markers that 
reflect an appetitive response towards drug cues - such as the startle response - are also 
important to identify unconscious aspects of craving behaviour, because many patients 
deny subjective craving when being exposed to a drug-associated cue but show strong 
appetitive reactions when assessed with the startle response (Heinz et al., 2003). 
Patients suffering from strong cue-reactivity and a high risk of relapse may specifically 
profit from specific psychotherapeutic treatments such as cue exposure. Although, cue 
exposure has repeatedly been investigated in evaluative studies on the average, this 
treatment approach does not seem to result in significantly better outcome than standard 
therapy with cognitive-behavioural therapy and supportive interventions (Kavanagh et al., 
2004; Löber et al., 2006). However, cue exposure may work best among patients with strong 
neuronal responses to alcohol cues, i.e. the identification of a subgroup of such patients may 
help to provide successful treatment strategies. 
Brain imaging is also used to assess the effects of additive pharmacotherapy on cue-induced 
neuronal activation patterns during abstinence (e.g. Hermann et al., 2006). Myrick and 
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inpatients until complete remission of physical withdrawal symptoms (Boothby & Doering, 
2005). It has been suggested that exposure to stress and to priming doses of alcohol can 
induce a relapse (Adinoff, 2004; Breese et al., 2005; Cooney, 1997). Another relevant 
mechanism that contributes to the risk of relapse is the exposure to stimuli that have 
regularly been associated with alcohol intake (contextual cues). Such stimuli have become 
conditioned cues that can elicit conditioned responses such as alcohol or drug craving and 
consumption behaviour (Adinoff, 2004; Berridge & Robinson, 1998; Di Chiara & Bassareo, 
2007; Everitt & Robbins 2005). In such situations, patients may experience craving for 
alcohol or the specific drug, which is based on the natural tendency to avoid unpleasant 
experiences, e.g. a conditioned withdrawal response to the presentation of drug cues in the 
absence of drug intake. Indeed, about one third of all alcoholics in a clinical setting 
described that their relapse was preceded by a sudden manifestation of withdrawal. It often 
occurred long after acute detoxification and was often triggered by “typical” drinking 
situations (Heinz et al., 2003). 
Although some imaging studies investigated the association between brain activation 
elicited by alcohol-associated stimuli and alcohol craving (see also 3.2), only few studies 
assessed to what extent cue-induced brain activation can predict the prospective relapse risk 
and therefore the clinical relevance of such imaging studies. Braus and colleagues (2001) 
reported that alcohol cues elicited increased activation of the ventral striatum and visual 
association cortices in detoxified alcoholics, and that patients who had experienced multiple 
relapses in the past showed a stronger cue-induced activity in the ventral striatum than 
patients who successfully abstained from alcohol for longer periods of time. This result was 
confirmed by Grüsser and colleagues (2004), who compared subsequently relapsing with 
abstaining patients. The latter group showed less brain activation elicited by visual alcohol-
associated stimuli in the anterior cingulate cortex, the adjacent ventral and medial prefrontal 
cortex and central parts of the striatum. As the striatum, mainly the dorsal part, has been 
suggested to be crucial for habit learning, this result might reflect differences in the habitual 
character of addictive behaviour between abstaining and relapsing patients, even in the 
absence of conscious drug urges (“craving”). These observations are in the line with studies 
in animals, in which cue-induced relapse after cocaine consumption was prevented by 
blockade of dopamine and AMPA glutamate receptors in the dorsal striatum 
(Vanderschuren et al., 2005). Thus, when talking about relapse risk, it seems to be of 
importance to distinguish between the neuronal correlates of habitual drug intake (i.e. 
without conscious craving) and drug-intake following the subjective feeling of craving. 
Unfortunately, the empirical basis for coherence between craving for the substance of abuse 
and risk of relapse is not fully satisfying. Although animal models strongly support the 
hypothesis that conditioned drug reactions are involved in the development and 
maintenance of addictive behaviour as well as relapse (Di Chiara, 2002; Robbins &Everitt, 
2002; Robinson & Berridge, 1993), studies in humans are rather heterogeneous. While some 
studies did not find a positive correlation between subjective i.e. conscious craving and 
relapse (Drummond & Glautier, 1994; Grüsser et al., 2004; Junghanns et al., 2005; Kiefer et 
al., 2005; Litt et al., 2000; Rohsenow et al., 1994), others did show significant correlations 
(Bottlender & Soyka, 2004; Cooney et al., 1997; Heinz et al., 2005b; Ludwig & Wikler, 1974; 
Monti et al., 1990). In contrast, changes in physiological parameters, including neuronal 
activation measured with functional imaging, seem to be more closely connected to relapse 
(Abrams et al., 1988; Braus et al., 2001; Drummond & Glautier, 1994; Grüsser et al., 2004; 
Rohsenow et al., 1994). Linking relapse risk with physiological responses may therefore be a 
more promising approach, and was used in several studies. 
To measure the effects of reactions to non-alcoholic, affectively positive and negative stimuli 
on the relapse risk, Heinz and colleagues (2007) briefly presented affective pictures to 
alcoholics versus control subjects while conducting fMRI measurements. The affectively 
positive pictures elicited increased brain activation in alcoholics in ventral striatum, which 
was negatively correlated with the subsequent relapse risk and may represent a protective 
factor against relapse. 
Dysfunctions of brain areas associated with executive control of behaviour (see also Figure 
3) may also contribute to relapse risk. Indeed, in methamphetamine-dependent patients, the 
subsequent relapse risk was predicted by activation patterns elicited during a two-choice 
decision-making task in the insula, posterior cingulate and temporal cortex (Paulus et al., 
2005). Similarly, Brewer and colleagues (2008) reported in cocaine dependent patients 
undergoing a stroop task an increased activation in regions relevant for cognitive control, 
including the anterior cingulate cortex, dorsolateral prefrontal cortex, as well as in the 
parietal lobule, insula and striatum. Longer duration of self-reported abstinence correlated 
with the strength of the activation of the ventromedial prefrontal cortex, left posterior 
cingulate cortex, and right striatum, percent drug-free urine screenings correlated with 
striatal activation, and treatment retention correlated with diminished activation of 
dorsolateral prefrontal cortex. Despite these promising examples, to date only few imaging 
studied followed the approach to predict relapse risk from the activity of brain areas 
associated with executive control of behaviour. 
 
5. Clinical implications 
Previous research in addiction suggests different therapeutic consequences. First of all, 
functional imaging studies help to understand the course of addiction development from its 
beginning up to its manifest state. Further, it can help to identify patients who are 
particularly at risk to relapse. As the described imaging techniques such as fMRI and PET 
are rather expensive, the transmission of these results on the application of less complicated 
techniques, which assess physiological responses to drug-associated cues, might be useful, 
e.g. the affect-modulated startle response (Heinz et al., 2003). Physiological markers that 
reflect an appetitive response towards drug cues - such as the startle response - are also 
important to identify unconscious aspects of craving behaviour, because many patients 
deny subjective craving when being exposed to a drug-associated cue but show strong 
appetitive reactions when assessed with the startle response (Heinz et al., 2003). 
Patients suffering from strong cue-reactivity and a high risk of relapse may specifically 
profit from specific psychotherapeutic treatments such as cue exposure. Although, cue 
exposure has repeatedly been investigated in evaluative studies on the average, this 
treatment approach does not seem to result in significantly better outcome than standard 
therapy with cognitive-behavioural therapy and supportive interventions (Kavanagh et al., 
2004; Löber et al., 2006). However, cue exposure may work best among patients with strong 
neuronal responses to alcohol cues, i.e. the identification of a subgroup of such patients may 
help to provide successful treatment strategies. 
Brain imaging is also used to assess the effects of additive pharmacotherapy on cue-induced 
neuronal activation patterns during abstinence (e.g. Hermann et al., 2006). Myrick and 
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colleagues (2008) were able to show that cue-induced activation of limbic brain areas is 
reduced by naltrexone and by the combination of naltrexone and ondansetron in detoxified 
alcoholics. Since alterations in the response to affective cues have been suggested to predict 
relapse (Heinz et al., 2007) these results may help to identify new pharmacological and 
psychological treatment strategies, such as the modulation of the central stress response (e.g. 
George et al., 2008). 
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